US Stock MarketDetailed Quotes
NCNA NuCana
- 1.0200
- -0.1100-9.73%
Close Jan 13 16:00 ET
- 1.0800
- +0.0600+5.88%
Post 20:01 ET
4.00MMarket Cap-0.07P/E (TTM)
1.1300High0.9601Low259.10KVolume1.1300Open1.1300Pre Close269.29KTurnover7.67%Turnover RatioLossP/E (Static)3.93MShares19.410052wk High0.75P/B3.45MFloat Cap0.960152wk Low--Dividend TTM3.38MShs Float800.0000Historical High--Div YieldTTM15.04%Amplitude0.9601Historical Low1.0390Avg Price1Lot Size
NuCana Stock Forum
Sign in to post a comment
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
7. I DO NOT give buy or sell advice
8. CH (cash on hand); AH (after hours): RTH (regular trading hours)
9. No buy pressure/momentum- No day trade.
10. Remember, some stocks may get pumped WITHOUT any catalyst this week ...
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
7. I DO NOT give buy or sell advice
8. CH (cash on hand); AH (after hours): RTH (regular trading hours)
9. No buy pressure/momentum- No day trade.
10. Remember, some stocks may get pumped WITHOUT any catalyst this week ...
136
50
35
$NuCana (NCNA.US)$
550% CTB loading 1.5 too 1.6
550% CTB loading 1.5 too 1.6
1
$NuCana (NCNA.US)$
EDINBURGH, United Kingdom, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that initial data from the ongoing Phase 1b/2 modular study (NuTide:303) investigating NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors (Module 1) and in combination with docetaxel for patients with lun...
EDINBURGH, United Kingdom, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that initial data from the ongoing Phase 1b/2 modular study (NuTide:303) investigating NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors (Module 1) and in combination with docetaxel for patients with lun...
$NuCana (NCNA.US)$
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
NuCana announced initial data from its Phase 1b/2 study of NUC-3373 in combination therapies. In Module 1, combining NUC-3373 with pembrolizumab showed promising results in 12 advanced solid tumor patients, achieving a 22% objective response rate and 67% disease control rate. Notable cases included a bladder cancer patient achieving 100% target ...
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
NuCana announced initial data from its Phase 1b/2 study of NUC-3373 in combination therapies. In Module 1, combining NUC-3373 with pembrolizumab showed promising results in 12 advanced solid tumor patients, achieving a 22% objective response rate and 67% disease control rate. Notable cases included a bladder cancer patient achieving 100% target ...
$NuCana (NCNA.US)$ 20$ target price , 1.5 mil float and lowest ever now .
1
$NuCana (NCNA.US)$ when should i cash out?
$NuCana (NCNA.US)$ is it gonna hit $3 tmr?
$NuCana (NCNA.US)$ You know i likes me some bottoms! 52wk low today! Also FINTEL showing this HTB listed with 100K LTB with a CTB 569.66%! Could be a bit squeezy with a nice buy side volume push! Hehehe! NFA just thinking outloud![]()
8
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Jason333 : Thanks . 🫶
72654027 阿弥陀佛 : Thank you.
ahhh_shicha__yabicha : You need to add eVTOL stocks, set to explode in 2025. I won't name them. Do your own research.
Jaguar8 OP ahhh_shicha__yabicha : Make your own watchlist. I have my own. This is DEC 30 watchlist. Not 2025
AlanTuring24 : Ever look at any stocks is the private market. For example Stoke Space?
View more comments...